UTX-TGR-205 (Unity NHL)

Trial description
A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 with or without Bendamustine and TGR-1202 alone in Patients with Previously Treated Non-Hodgkin’s Lymphoma. (Only open to Follicular and Marginal Zone Lymphomas)
Contact name
Dr Dan Hodson
Trial start date
Friday, December 29, 2017
Trial end date
Tuesday, December 29, 2020
Trial tumour type
Haematological
Show on Radiotherapy
No